For topical skincare, timing is a minor optimization, twice-daily use is a sensible default, but consistency over weeks matters far more than hitting an exact hour
Light protection GHK-Cu demonstrates significant light sensitivity due to copper-catalyzed photodegradation
In comparison to Grade I and II histology, Grade III histology was found to be a risk factor for adverse breast cancer outcomes ( P = 0.018)
GHK-Cu signals fibroblasts, but fibroblasts still need raw materials
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Important: Risks Associated with Glutathione Injections (Not Oral Liquid) The following risks are associated primarily with IV glutathione injections and whitening drips not oral liquid glutathione: Kidney damage linked to high-dose, unregulated IV therapy Nerve-related complications in some reported cases Severe skin reactions such as Stevens-Johnson syndrome (extremely rare) Risk of infections from non-sterile needles or unsafe administration These complications are not associated with properly formulated oral glutathione supplements